Knights Of Columbus Asset Advisors LLC Viking Therapeutics, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.5 Billion
- Q2 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 42,254 shares of VKTX stock, worth $2.78 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
42,254
Previous 41,836
1.0%
Holding current value
$2.78 Million
Previous $3.43 Million
34.72%
% of portfolio
0.15%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
478Shares Held
66.1MCall Options Held
6.24MPut Options Held
3.01M-
Vanguard Group Inc Valley Forge, PA10.1MShares$665 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$397 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$337 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$148 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$122 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...